100.26
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$100.30
Offen:
$99.99
24-Stunden-Volumen:
16.63M
Relative Volume:
1.24
Marktkapitalisierung:
$248.85B
Einnahmen:
$63.90B
Nettoeinkommen (Verlust:
$19.05B
KGV:
13.26
EPS:
7.5596
Netto-Cashflow:
$13.05B
1W Leistung:
+1.34%
1M Leistung:
+7.90%
6M Leistung:
+22.70%
1J Leistung:
-1.71%
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Vergleichen Sie MRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MRK
Merck Co Inc
|
100.26 | 248.95B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,062.19 | 919.64B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
214.17 | 509.76B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
227.45 | 394.69B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
135.19 | 254.37B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck Stock (MRK) News Today: BofA Raises Target to $120 as Winrevair Expansion and Dividend Date Spotlight 2026 Outlook - ts2.tech
Gilead's Experimental Combo Tablet For HIV Treatment Hits Primary Goal - Benzinga
Merck & Co's Options: A Look at What the Big Money is Thinking - Benzinga
Valeo Financial Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
V. M. Manning & CO. Inc. Invests $1.17 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Bank of America Analyst Says - MarketBeat
Neville Rodie & Shaw Inc. Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Texas Permanent School Fund Corp - MarketBeat
Stance Capital LLC Invests $1.26 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kestra Investment Management LLC - MarketBeat
Rep. Julie Johnson Sells Off Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Cullen Capital Management LLC Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Corient Private Wealth LLC - MarketBeat
Merck & Co., Inc.: - marketscreener.com
Merck stock (MRK): News, dividend date, Keytruda updates and analyst forecasts to watch before the U.S. market opens Dec. 15, 2025 - ts2.tech
MASTERINVEST Kapitalanlage GmbH Invests $2.92 Million in Merck & Co., Inc. $MRK - MarketBeat
Sterile Bioprocess Filtration Market to Hit USD 21.20 Billion by 2032, Driven by Rising Biologics Production and Adoption of Single Use Filtration Technologies - GlobeNewswire Inc.
Immuno-oncology Clinical Trials Market Projected to Reach USD 23.63 Billion by 2032 at a CAGR of 12.37% - GlobeNewswire Inc.
Thrivent Financial for Lutherans Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Kentucky Retirement Systems Lowers Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Thompson Davis & CO. Inc. Invests $1.17 Million in Merck & Co., Inc. $MRK - MarketBeat
North Dallas Bank & Trust Co. Invests $919,000 in Merck & Co., Inc. $MRK - MarketBeat
National Bank of Canada FI Boosts Position in Merck & Co., Inc. $MRK - MarketBeat
Public Sector Pension Investment Board Reduces Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Evergreen Capital Management LLC - MarketBeat
B. Riley Wealth Advisors Inc. Takes Position in Merck & Co., Inc. $MRK - MarketBeat
LM Advisors LLC Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Lazard Asset Management LLC - MarketBeat
Bcwm LLC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Curi Capital LLC Buys 65,987 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bridgeway Capital Management LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Brevan Howard Capital Management LP Buys Shares of 448,919 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Lifted by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Benjamin Edwards Inc. Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Guggenheim lifts PT on Merck & Co. (MRK) to $122 from $104 - MSN
Bellevue Group AG Sells 203,132 Shares of Merck & Co., Inc. $MRK - MarketBeat
Banque Transatlantique SA Sells 418,552 Shares of Merck & Co., Inc. $MRK - MarketBeat
AQR Capital Management LLC Buys 1,029,454 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co Inc (MRK) Price Today - CoinMarketCap
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.3% After Analyst Upgrade - MarketBeat
Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025) - ts2.tech
Merck & Co (MRK) Analyst Ratings Update: Morgan Stanley Raises P - GuruFocus
Merck & Co., Inc. (NYSE:MRK) Given New $102.00 Price Target at Morgan Stanley - MarketBeat
Morgan Stanley Adjusts Merck & Co. PT to $102 From $100, Maintains Equalweight Rating - marketscreener.com
Merck Receives Positive EU CHMP Opinion For Expanded Use Of WINREVAIR In Adults With Pulmonary Arterial Hypertension - TradingView — Track All Markets
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) - Business Wire
Peapack Gladstone Financial Corp Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Ieq Capital LLC Acquires 348,203 Shares of Merck & Co., Inc. $MRK - MarketBeat
HUB Investment Partners LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Sei Investments Co. - MarketBeat
CIBC Asset Management Inc Sells 78,956 Shares of Merck & Co., Inc. $MRK - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):